Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol to prevent GFR loss in type 1 diabetes
2013-003481-14Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of allopurinol in diabetic glomerulosclerosis, diabetes mellitus type 1 (T1D) and hyperuricemia (2 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Feb 2014; status: completed.
02
Drugs
allopurinol
03
Conditions
diabetic glomerulosclerosisdiabetes mellitus type 1 (T1D)hyperuricemia
Beyond the preview
Go deeper on 2013-003481-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003481-14.